Table of Contents
- Overview
- Symptoms
- Treatment
- Prevention
Thromboembolic states; Factor V Leiden; Prothrombin mutation 20210A
Treatment
Support Groups
Expectations (prognosis)
Complications
Calling your health care provider
Review Date: 10/06/2010
Reviewed By: David C. Dugdale, III, MD, Professor of Medicine, Division of
General Medicine, Department of Medicine, University of Washington
School of Medicine; James R. Mason, MD, Oncologist, Director, Blood
and Marrow Transplantation Program and Stem Cell Processing Lab,
Scripps Clinic, Torrey Pines, California. Also reviewed by David
Zieve, MD, MHA, Medical Director, A.D.A.M., Inc.
A.D.A.M., Inc. is accredited by URAC, also known as the American Accreditation HealthCare Commission (www.urac.org)
